Dr Esther Lim - Funded 2016
PROJECT: Immunotherapy for Melanoma
GOAL: To find ways to boost the human immune system to improve the effectiveness of current melanoma therapies
Dr Lim is based at Macquarie University Hospital and is researching immunotherapy for melanoma. She is determined to make a difference, specifically in finding ways to boost the human immune system to improve the effectiveness of current melanoma therapies.
What does the research entail? Esther is investigating inhibitors for a certain protein pathway in the body known as MAPK, which plays a key role in the development of melanoma. Work in the field has already improved survival rates of the 30% to 40% of Australian patients who have a form of the disease known as “BRAF-mutant” melanoma.
Help fund more vital cancer research
